#pharmaceuticals
Related Stories (18)
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug - Reuters
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug Reuters
May 14, 2026US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs - Reuters
US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs Reuters
April 30, 2026Novartis misses quarterly sales, profit estimates as Entresto generics hit growth - Reuters
Novartis misses quarterly sales, profit estimates as Entresto generics hit growth Reuters
April 28, 2026India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal - Reuters
India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal Reuters
April 27, 2026Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say - Reuters
Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say Reuters
April 22, 2026US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims - Reuters
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims Reuters
April 17, 2026Amazon launches AI research tool to speed early-stage drug discovery - Reuters
Amazon launches AI research tool to speed early-stage drug discovery Reuters
April 14, 2026Replimune's drug for advanced skin cancer fails to win FDA nod again - Reuters
Replimune's drug for advanced skin cancer fails to win FDA nod again Reuters
April 10, 2026Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery - Reuters
Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery Reuters
April 9, 2026Pharmaceuticals face 100% tariffs in US - unless firms strike a deal
The order does not affect generic medicines, the most commonly used in the US.
April 2, 2026Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters
March 25, 2026The cutthroat battle for the US weight-loss drug market
Weight-loss drug prices are falling in the US - but can the example be repeated?
March 23, 2026Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit - Reuters
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit Reuters
March 9, 2026Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters
Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports Reuters
March 7, 2026Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say - Reuters
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Reuters
February 25, 2026Novo Nordisk to halve US list price of Wegovy from 2027 - Reuters
Novo Nordisk to halve US list price of Wegovy from 2027 Reuters
February 24, 2026Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out - Reuters
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out Reuters
February 23, 2026Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20% - Reuters
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOLXJ6YWlYcmIyRDdRMjQ0SjhrNTFpQi0ySm5TRnFQdnhWZEY2MXpHUXY3RXM4b185Y01EalZDT3duNjNQNTVqcnMxRUJMaFUxVkNBZ1JpSmNYNlBLQWlKRmdsOS1zS0FmZVRpQW44MnlvUl9CekxOREZleUNLbFlZUmItZF90V2lyWU0xa0doZmNQWDg1dXZiOWJEYWFkQmgwZW1EQ2FxMF94c0xEQlZzLTJJNUFEYmtuV3c?oc=5" target="_blank">Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20%</a> <font color="#6f6f6f">Reuters</font>
February 20, 2026